A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer’s disease

Bicyclic peptides have great therapeutic potential since they can bridge the gap between small molecules and antibodies by combining a low molecular weight of about 2 kDa with an antibody-like binding specificity. Here we apply a recently developed in silico rational design strategy to produce a bic...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Sci Rep
Главные авторы: Ikenoue, Tatsuya, Aprile, Francesco A., Sormanni, Pietro, Ruggeri, Francesco S., Perni, Michele, Heller, Gabriella T., Haas, Christian P., Middel, Christoph, Limbocker, Ryan, Mannini, Benedetta, Michaels, Thomas C. T., Knowles, Tuomas P. J., Dobson, Christopher M., Vendruscolo, Michele
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group UK 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7498612/
https://ncbi.nlm.nih.gov/pubmed/32943652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-69626-3
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы